Stock
Daily Margin Trading Facility book for Abbott India across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.
What is Abbott India’s MTF book?
Abbott India Limited (ABBOTINDIA) has ₹38 crore funded under Margin Trading Facility across NSE and BSE as of 26 Oct 2026 — 0.03% of India’s MTF book, ranking #761. Over 1M (the last 30 trading days) the funded value has fallen 41.2%, with the number of shares under margin down 41.8%.
Funded value
₹38 Cr
as of 26 Oct 2026
Rank in book
#761
1,862 days tracked
Share of book
0.03%
of the whole NSE + BSE book
Peak funded
₹76 Cr
on 05 May 2026
Largest single-day addition
+₹9 Cr
on 30 Nov 2021
Largest single-day unwind
−₹11 Cr
on 18 Sep 2026
Market cap
₹53,601 Cr
Mid cap · free float not yet filed
MTF share of free float
—
needs a free-float filing
Dated events
- 01 Aug 2017First recorded in the MTF book
NSE & BSE split
How ABBOTINDIA’s funded book divides across the two exchanges, as of 26 Oct 2026.
NSE ₹37 Cr · 97.1%BSE ₹1 Cr · 2.9%
MTF vs Price
Margin-funded outstanding for ABBOTINDIA in ₹ crore
against the closing price, adjusted for splits and bonuses. Each window uses
the same reference date as the table below, so the two agree. Funded value
moves with the price on its own, so the line under the chart reads the
share count instead — that is what shows whether more stock is
genuinely being borrowed against.
MTF book (₹ Cr)
Close price (₹)
Price and liquidity
Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹25,030.00
as of 23 Oct 2026
Price, 1M
−0.8%
adjusted for splits and bonuses
Delivery, 20-day avg
52.8%
of traded volume actually settled
Sessions to unwind
5
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.
Book, shares and price by window
Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
| Window | Book Δ | Book % | Shares | Price | Reading |
|---|---|---|---|---|---|
| 1D | −₹1 | −2.8% | −2.7% −380 | +0.0% | unwinding as it falls |
| 10D | −₹7 | −15.1% | −15.0% −2,396 | −3.7% | unwinding as it falls |
| 1M | −₹26 | −41.2% | −41.8% −9,769 | −0.8% | unwinding as it falls |
| 3M | −₹20 | −34.5% | −35.2% −7,399 | −10.6% | unwinding as it falls |
| 6M | −₹36 | −48.4% | −49.9% −13,585 | −0.6% | unwinding as it falls |
| 1Y | +₹0 | +0.3% | +13.2% +1,585 | −16.4% | building as it falls |
Shares under margin
Number of shares funded via MTF over time (NSE + BSE combined).
Rank trajectory
Where ABBOTINDIA has sat in the funded-value ranking each day
(1 = most funded). Lower is more prominent.
ABBOTINDIA — last 30 trading days
Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
| Date | Combined (₹ Cr) | Day Δ (₹ Cr) | % of book | Rank |
|---|---|---|---|---|
| 26 Oct 2026 | 38 | −₹1 | 0.03% | 761 |
| 23 Oct 2026 | 39 | −₹2 | 0.03% | 755 |
| 22 Oct 2026 | 41 | −₹0 | 0.03% | 746 |
| 21 Oct 2026 | 41 | −₹1 | 0.03% | 746 |
| 19 Oct 2026 | 42 | +₹0 | 0.03% | 738 |
| 16 Oct 2026 | 42 | −₹0 | 0.03% | 744 |
| 15 Oct 2026 | 42 | +₹0 | 0.03% | 743 |
| 14 Oct 2026 | 42 | −₹3 | 0.03% | 744 |
| 13 Oct 2026 | 45 | −₹0 | 0.03% | 708 |
| 12 Oct 2026 | 45 | +₹1 | 0.03% | 707 |
| 09 Oct 2026 | 44 | −₹1 | 0.03% | 716 |
| 08 Oct 2026 | 46 | +₹1 | 0.03% | 706 |
| 07 Oct 2026 | 45 | +₹0 | 0.03% | 709 |
| 06 Oct 2026 | 45 | +₹2 | 0.03% | 706 |
| 05 Oct 2026 | 43 | +₹1 | 0.03% | 726 |
| 01 Oct 2026 | 42 | −₹1 | 0.03% | 729 |
| 30 Sep 2026 | 43 | −₹0 | 0.03% | 728 |
| 29 Sep 2026 | 44 | −₹4 | 0.03% | 724 |
| 28 Sep 2026 | 47 | −₹1 | 0.03% | 688 |
| 25 Sep 2026 | 48 | −₹0 | 0.03% | 675 |
| 24 Sep 2026 | 48 | +₹0 | 0.03% | 673 |
| 23 Sep 2026 | 48 | +₹0 | 0.03% | 673 |
| 22 Sep 2026 | 48 | −₹1 | 0.03% | 675 |
| 21 Sep 2026 | 49 | −₹1 | 0.03% | 665 |
| 18 Sep 2026 | 50 | −₹11 | 0.03% | 653 |
| 17 Sep 2026 | 61 | −₹1 | 0.04% | 575 |
| 16 Sep 2026 | 61 | −₹1 | 0.04% | 566 |
| 15 Sep 2026 | 62 | −₹3 | 0.04% | 570 |
| 11 Sep 2026 | 65 | +₹0 | 0.04% | 551 |
| 10 Sep 2026 | 65 | — | 0.04% | 555 |
ABBOTINDIA within Health Technology
Ranked #43 of 61 funded Health Technology stocks, carrying 0.6% of that sector’s margin book. Nearest names by funded value:
| # | Stock | MTF book (₹ Cr) | % of sector | % of free float | Book, 1M |
|---|---|---|---|---|---|
| 41 | STARStrides Pharma Science | ₹40 | 0.6% | 0.60% | +3.6% |
| 42 | HIKALHikal Limited | ₹38 | 0.6% | 4.16% | −10.3% |
| 43 | ABBOTINDIAAbbott India | ₹38 | 0.6% | — | −41.2% |
| 44 | TORNTPHARMTorrent Pharmaceuticals | ₹37 | 0.6% | 0.05% | −3.4% |
| 45 | JUBLPHARMAJubilant Pharmova | ₹37 | 0.6% | 0.43% | +16.6% |
Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.